Alcon Dodges FCA Suit Over Eye Drug Marketing

Law360, New York (August 27, 2013, 7:28 PM ET) -- A former Alcon Laboratories Inc. employee on Monday dropped a whistleblower lawsuit alleging the pharmaceutical company violated the False Claims Act by marketing eye drugs off-label, after the federal government refused to take up the case.

Former Alcon employee Michael Jackson had claimed that the company used improper incentives to push doctors to prescribe the drugs Vigamox and Nevanac, which can be used to treat certain eye conditions.

Jackson, a former Alcon sales representative, filed his suit against the Texas-based company under seal in October 2009,...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required